Dr. Chih-Tsung Yang is a THRF EMCR Fellow at the Future Industries Institute. His interdisciplinary research expertise is centred on the fields of biomaterials, biosensing, microfluidics and organ-on-a-chip models. His current research is focused on the development of bioengineered human organs-on-a-chip models to evaluate the therapeutic efficiency of nanomedicine and radiation therapy protocols.
Dr. Yang is currently leading an ambitious research program “Towards Precision Cancer Radiotherapy: Development of a Radiogenomic Tool through Patient-Derived Tumour on-Chips Reconstructing the Tumour Microenvironment”. His most recent work has been focused on the development of bioengineered tumour/tissue models aimed ... Read more
About me
Dr. Chih-Tsung Yang is a THRF EMCR Fellow at the Future Industries Institute. His interdisciplinary research expertise is centred on the fields of biomaterials, biosensing, microfluidics and organ-on-a-chip models. His current research is focused on the development of bioengineered human organs-on-a-chip models to evaluate the therapeutic efficiency of nanomedicine and radiation therapy protocols.
Dr. Yang is currently leading an ambitious research program “Towards Precision Cancer Radiotherapy: Development of a Radiogenomic Tool through Patient-Derived Tumour on-Chips Reconstructing the Tumour Microenvironment”. His most recent work has been focused on the development of bioengineered tumour/tissue models aimed at providing new insight of the effect of ionizing radiation and, ultimately, at informing the design of better and safer radiotherapy algorithms. He initiated and coordinated the approval of the MOU between UniSA and Chang Gung University/Chang Gung Memorial Hospital (CGMH, Taiwan) in the field of proton beam therapy. He is also leading and coordinating several research projects with the proton beam therapy centre at CGMH.
Prior to the start of his PhD, he significantly contributed to the liquid biopsy technology that underpinned the successful spin-off of CellMax Life ($15 million from VCs). As an emerging leader in his field, he contributed directly to more than 30 publications in high-quality peer-reviewed journals, which is evidenced by the fact that 25 are published in Q1 journals in their field. Dr. Yang is actively engaged in his research community and is regularly invited to serve as a reviewer for peer-reviewed scientific journals (ACS Biomaterials Science & Engineering, ACS Applied Materials and Interfaces, Sensors, Optical Materials, Plos One and Applied Sciences). He is the UniSA node project leader of the signature project “Development of bioengineered multicellular systems” of the ARC Centre of Excellence for Convergent Bio-Nano Science &Technology (CBNS).
About me
American Chemical Society 2019-
Australian Society of Medical Research 2018-
Australasian Biotechnology 2016-
Australian Nanotechnology Network (ANN) 2013-
About me
Date | Title |
---|---|
05/02/2023 |
New technology developed to diagnose porcine epidemic diarrhoea virus in pigs, https://www.theland.com.au/story/8072890/probing-researchers-strike-gold-to-stop-the-trots-in-pigs/ |
03/02/2023 |
Breakthrough in Detection of Lethal Pig Virus, https://www.technologynetworks.com/tn/news/breakthrough-in-detection-of-lethal-pig-virus-369848 |
02/02/2023 |
Probing researchers strike gold to stop the trots in pigs, https://www.eurekalert.org/news-releases/978627 |
27/02/2022 |
Improving Cancer Survivors’ Quality Of Life Headlines $1.7m Grants, https://hospitalresearch.org.au/news/latest-news/improving-cancer-survivors-quality-of-life-headlines-1-7m-grants/ |
18/03/2019 |
Aussies and Americans develop 3D models for assessing impacts of radiotherapy, https://www.dotmed.com/news/story/46575 |
14/03/2019 |
Using 3D models to reduce side effects of radiotherapy, https://www.eurekalert.org/pub_releases/2019-03/uosa-u3m031219.php |
13/03/2019 |
3D models help reduce side effects of radiation therapy, https://www.appliedradiationoncology.com/articles/3d-models-help-reduce-side-effects-of-radiation-therapy |
12/03/2019 |
Microfluidic chip could reduce radiotherapy side effects, http://theleadsouthaustralia.com.au/industries/health/microfluidic-chip-could-reduce-radiotherapy-side-effects/ |
12/03/2019 |
Microfluidic chip could reduce radiotherapy side effects, https://phys.org/news/2019-03-microfluidic-chip-radiotherapy-side-effects.html |
Development of microphysiological organ-on-chip towards precision radiotherapy.
● Linking response to radiation therapies with glioblastoma cell phenotype
● "Micropocket" for high-throughput preparation of tumouroids and screening of radiosensitisers
● Pumpless microfluidic perfusion device for long-term culture of brain tissue slices
● Development ofglioblastoma radiotherapy prognosis radiogenomic model
● 3D printed microtissue cassette for quantification of proton relative biological effectiveness
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2024 |
Open access
2
2
|
2023 |
17
16
3
|
2023 |
Open access
24
21
|
2022 |
Open access
9
9
|
2019 |
30
28
58
|
Year | Output |
---|---|
2025 |
|
2025 |
Open access
|
2024 |
Open access
2
2
|
2024 |
Open access
1
1
|
2024 |
Open access
|
2024 |
Open access
2
2
|
2023 |
17
16
3
|
2023 |
Open access
24
21
|
2023 |
Open access
11
10
1
|
2022 |
Open access
9
9
|
2022 |
Open access
6
6
43
|
2021 |
Open access
13
14
|
2021 |
Open access
23
22
|
2021 |
1
1
|
2021 |
Open access
15
14
|
2020 |
18
18
1
|
2020 |
Open access
5
5
|
2019 |
30
28
58
|
2019 |
Open access
17
16
1
|
2019 |
Open access
23
21
1
|
2019 |
13
11
7
|
2018 |
Open access
20
21
1
|
2017 |
28
24
|
2017 |
44
41
|
2016 |
Open access
64
54
15
|
2016 |
Open access
56
51
51
|
2016 |
28
29
4
|
2016 |
27
24
|
2015 |
7
7
|
2014 |
9
9
|
2014 |
50
45
|
2010 |
27
25
|
2009 |
24
23
|
Research
Development of microphysiological organ-on-chip towards precision radiotherapy.
● Linking response to radiation therapies with glioblastoma cell phenotype
● "Micropocket" for high-throughput preparation of tumouroids and screening of radiosensitisers
● Pumpless microfluidic perfusion device for long-term culture of brain tissue slices
● Development ofglioblastoma radiotherapy prognosis radiogenomic model
● 3D printed microtissue cassette for quantification of proton relative biological effectiveness
External engagement & recognition
Organisation | Country |
---|---|
Academia Sinica | TAIWAN |
Agency for Science, Technology and Research (A*STAR) | SINGAPORE |
Chang Gung Memorial Hospital | TAIWAN |
Chang Gung University | TAIWAN |
China Medical University, Taiwan | TAIWAN |
Chinese Academy of Sciences | CHINA |
Dana-Farber Cancer Institute | UNITED STATES |
Flinders University | AUSTRALIA |
Forschungszentrum Julich | GERMANY |
Fudan University | CHINA |
Guilin University of Electronic Technology | CHINA |
High Performance Computing | SINGAPORE |
Jiangsu University of Science and Technology | CHINA |
Nanjing Agricultural University | CHINA |
Nanjing Forestry University | CHINA |
Nanjing Medical University | CHINA |
Nanjing University | CHINA |
Nanyang Technological University | SINGAPORE |
National Central University | TAIWAN |
National Defense Medical Center | TAIWAN |
Peter Grunberg Institute (PGI) | GERMANY |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Shanghai University of Traditional Chinese Medicine | CHINA |
Shimadzu Biomedical Research Laboratory | CHINA |
Siemens Healthcare Adelaide | AUSTRALIA |
Siemens Healthcare Germany | GERMANY |
Siemens Healthineers International AG | SWITZERLAND |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
Southeast University | CHINA |
Stanford University | UNITED STATES |
Tabriz University of Medical Sciences | IRAN |
The Chinese University of Hong Kong (CUHK) | CHINA |
The University of Tennessee Health Science Center | UNITED STATES |
University of California | UNITED STATES |
University of Edinburgh | UNITED KINGDOM |
University of North Carolina at Chapel Hill | UNITED STATES |
University Of Oklahoma Norman | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
Yangzhou University | CHINA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
THRF EMCR FellowshipThe Hospital Research Foundation Group |
2022 |
Guest peer reviewerPLos One |
2016 |
Guest peer reviewerOptical Materials |
2016 |
Guest peer reviewerElsevier Publishing |
2016 |
Keystone Symposia Future of Science Scholarship 2019
UniSA Coordinator Honours research projects 2018-
ARC CBNS UniSA node project leader 2017-
Member of The Phi Tau Phi Scholastic Honor Society, Taiwan 2002-
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
New radiobiological insights using a microphysiological device enabling long-term culture of patient-derived brain tumour tissue slices and cerebral organoid slices | Current |
Next generation bioengineered in vitro tumour models | Current |
Bioengineered vascularized microfluidic model: towards improved cancer therapy risk reduction and in vitro evaluation of the metastatic process | Completed |
Development of a solid-state biodiagnostic platform based on indium oxide nanoribbon field effect transistors | Completed |
Single cell analysis of gold and gold-core/silica-shell nanoparticles for radiosensitisation | Completed |